Summitry LLC’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-51,430
| Closed | -$2.37M | – | 90 |
|
|
2020
Q4 | $2.37M | Buy |
51,430
+1,956
| +4% | +$90K | 0.17% | 52 |
|
|
2020
Q3 | $2.33M | Buy |
49,474
+520
| +1% | +$24.5K | 0.19% | 54 |
|
|
2020
Q2 | $2.5M | Buy |
48,954
+4,109
| +9% | +$210K | 0.21% | 52 |
|
|
2020
Q1 | $2.12M | Buy |
44,845
+1,851
| +4% | +$87.7K | 0.19% | 48 |
|
|
2019
Q4 | $2.53M | Buy |
42,994
+3,356
| +8% | +$197K | 0.2% | 45 |
|
|
2019
Q3 | $2.12M | Buy |
39,638
+2,360
| +6% | +$126K | 0.17% | 52 |
|
|
2019
Q2 | $1.87M | Buy |
37,278
+844
| +2% | +$42.2K | 0.15% | 53 |
|
|
2019
Q1 | $1.9M | Buy |
36,434
+2,980
| +9% | +$156K | 0.17% | 49 |
|
|
2018
Q4 | $1.6M | Buy |
33,454
+5,378
| +19% | +$257K | 0.16% | 45 |
|
|
2018
Q3 | $1.41M | Buy |
28,076
+843
| +3% | +$42.3K | 0.12% | 55 |
|
|
2018
Q2 | $1.37M | Buy |
27,233
+2,185
| +9% | +$110K | 0.13% | 53 |
|
|
2018
Q1 | $1.22M | Buy |
25,048
+3,048
| +14% | +$149K | 0.11% | 56 |
|
|
2017
Q4 | $975K | Buy |
22,000
+2,752
| +14% | +$122K | 0.09% | 57 |
|
|
2017
Q3 | $977K | Buy |
19,248
+3,224
| +20% | +$164K | 0.09% | 57 |
|
|
2017
Q2 | $864K | Buy |
16,024
+1,316
| +9% | +$71K | 0.08% | 57 |
|
|
2017
Q1 | $775K | Buy |
14,708
+764
| +5% | +$40.3K | 0.07% | 58 |
|
|
2016
Q4 | $671K | Buy |
13,944
+1,020
| +8% | +$49.1K | 0.07% | 59 |
|
|
2016
Q3 | $697K | Buy |
12,924
+1,420
| +12% | +$76.6K | 0.07% | 58 |
|
|
2016
Q2 | $623K | Buy |
11,504
+4,544
| +65% | +$246K | 0.06% | 59 |
|
|
2016
Q1 | $353K | Buy |
6,960
+1,772
| +34% | +$89.9K | 0.04% | 68 |
|
|
2015
Q4 | $262K | Buy |
+5,188
| New | +$262K | 0.03% | 70 |
|